Pyxis Oncology, Inc. (PYXS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 11.04M | 0 | 2.82M | 0 | 0 | 0 | 0 | 16.15M | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | -100% | - | - | - | - | - | - | - |
| Cost of Goods Sold | 459K | -432K | 0 | 0 | 0 | 0 | 0 | 0 | 475K | 0 | 0 | 0 |
| COGS % of Revenue | - | -3.91% | - | - | - | - | - | - | 2.94% | - | - | - |
| Gross Profit | -459K | 11.47M | 0 | 2.82M | 0 | 0 | 0 | 0 | 15.67M | 0 | 0 | 0 |
| Gross Margin % | - | 103.91% | - | 100% | - | - | - | - | 97.06% | - | - | - |
| Gross Profit Growth % | - | - | - | - | -100% | - | - | - | - | - | - | - |
| Operating Expenses | 23.9M | 29.77M | 23.46M | 22.57M | 22.91M | 40.07M | 23.75M | 20.03M | 21.28M | 17.77M | 25.35M | 18.12M |
| OpEx % of Revenue | - | 269.66% | - | 800.35% | - | - | - | - | 131.77% | - | - | - |
| Selling, General & Admin | 4.38M | 5.23M | 4.97M | 5.44M | 5.87M | 5.08M | 6.01M | 6.08M | 8.25M | 6.16M | 10.67M | 6.73M |
| SG&A % of Revenue | - | 47.42% | - | 192.8% | - | - | - | - | 51.08% | - | - | - |
| Research & Development | 19.59M | 21.71M | 17.81M | 17.13M | 17.04M | 14.02M | 17.74M | 13.95M | 13.03M | 11.61M | 14.69M | 11.39M |
| R&D % of Revenue | - | 196.69% | - | 607.55% | - | - | - | - | 80.69% | - | - | - |
| Other Operating Expenses | -71K | 1000K | 684K | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -24.36M | -18.3M | -23.46M | -19.75M | -22.91M | -40.07M | -23.75M | -20.03M | -5.61M | -17.77M | -25.35M | -18.12M |
| Operating Margin % | - | -165.75% | - | -700.35% | - | - | - | - | -34.71% | - | - | - |
| Operating Income Growth % | -6.31% | 54.34% | 1.23% | 1.41% | -308.81% | -125.52% | 6.31% | -10.55% | 73.25% | 53.21% | 10.7% | 29.56% |
| EBITDA | -23.9M | -15.41M | -22.93M | -19.21M | -22.36M | -39.52M | -23.02M | -19.45M | -4.49M | -17.08M | -24.83M | -17.6M |
| EBITDA Margin % | - | -139.57% | - | -681.38% | - | - | - | - | -27.8% | - | - | - |
| EBITDA Growth % | -6.88% | 61.02% | 0.42% | 1.19% | -398.15% | -131.42% | 7.28% | -10.51% | 78.38% | 54.8% | 11.92% | 31.17% |
| D&A (Non-Cash Add-back) | 459K | 2.89M | 535K | 535K | 552K | 550K | 731K | 585K | 1.12M | 690K | 523K | 524K |
| EBIT | -24.36M | -18.3M | -22M | -19.75M | -22.91M | -19.11M | -23.75M | -20.03M | -5.61M | -17.77M | -25.35M | -18.12M |
| Net Interest Income | 457K | 600K | 774K | 995K | 1.24M | 1.62M | 1.85M | 2.02M | 1.55M | 1.59M | 1.71M | 1.66M |
| Interest Income | 457K | 600K | 774K | 995K | 1.24M | 1.62M | 1.85M | 2.02M | 1.55M | 1.59M | 1.71M | 1.66M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.09M | 1.29M | 1.46M | 1.68M | 1.76M | 2.33M | 2.55M | 2.73M | 2.35M | 2.17M | 2.31M | 2.22M |
| Pretax Income | -23.27M | -17M | -22M | -18.07M | -21.16M | -37.73M | -21.2M | -17.3M | -3.26M | -15.6M | -23.05M | -15.9M |
| Pretax Margin % | - | -154.04% | - | -640.82% | - | - | - | - | -20.17% | - | - | - |
| Income Tax | 0 | 1.1M | 0 | 283K | 0 | -2.16M | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -6.49% | 0% | -1.57% | 0% | 5.73% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -23.27M | -18.11M | -22M | -18.35M | -21.16M | -35.57M | -21.2M | -17.3M | -3.26M | -15.6M | -23.05M | -15.9M |
| Net Margin % | - | -164.03% | - | -650.85% | - | - | - | - | -20.17% | - | - | - |
| Net Income Growth % | -9.99% | 49.1% | -3.77% | -6.09% | -549.82% | -128.06% | 8.01% | -8.8% | 83.08% | 56.8% | 16.71% | 37.79% |
| Net Income (Continuing) | -23.27M | -18.11M | -22M | -18.35M | -21.16M | -35.57M | -21.2M | -17.3M | -3.26M | -15.6M | -23.05M | -15.9M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.37 | -0.29 | -0.35 | -0.30 | -0.35 | -0.58 | -0.35 | -0.29 | -0.06 | -0.35 | -0.56 | -0.41 |
| EPS Growth % | -5.71% | 50% | 0% | -3.45% | -451.18% | -65.71% | 37.5% | 29.27% | 87.3% | -153.85% | 32.53% | 47.44% |
| EPS (Basic) | -0.37 | -0.29 | -0.35 | -0.30 | -0.35 | -0.58 | -0.35 | -0.29 | -0.06 | -0.35 | -0.56 | -0.41 |
| Diluted Shares Outstanding | 63.47M | 62.14M | 62.56M | 61.92M | 61.05M | 60.72M | 60.72M | 60.5M | 51.29M | 44.75M | 41.33M | 38.39M |
| Basic Shares Outstanding | 63.47M | 62.14M | 62.56M | 61.92M | 61.05M | 60.72M | 60.72M | 60.5M | 51.29M | 44.75M | 41.33M | 38.39M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |